3rd Quarter - Report

AMERICAN OSTEOPATHIC ASSOCIATION for AMERICAN OSTEOPATHIC ASSOCIATION

Firm
Client
Income
—
Expenses
$151,909
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Insurance INS

Mental Health Parity, Chronic Disease Management

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Prior Authorization, Medicare Physician Payment, Expanding Medical Education, Mental Health Parity, Medical Student Loan Debt, Chronic Disease Management, SURS Extension Act, Budget Neutrality, PAYGO

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; White House Office; Executive Office of the President (EOP); Health Resources & Services Administration (HRSA)

Medical/Disease Research/Clinical Labs MED

Chronic Disease Management, Gun Violence Prevention

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Agency for Healthcare Research & Quality (AHRQ)

Medicare/Medicaid MMM

Medicare Advantage Prior Authorization, Medicare Physician Payment, Expanding Medical Education, Mental Health Parity, Chronic Disease Management, SURS Extension Act, Budget Neutrality, PAYGO

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: Executive Office of the President (EOP); White House Office; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Torts TOR

Good Samaritan Health Professionals Act, ACCESS Act, Federal COVID-19 Liability Immunity

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

N/A

LobbyistCovered position, as disclosed
DAVID PUGACH Sr. Vice President, Public Policy

Budget/Appropriations BUD

Teaching Health Center Graduate Medical Education, Expanding Medicare Medical Education, Medical Student Loan Debt, SURS Extension Act, Budget Neutrality, PAYGO

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: Health Resources & Services Administration (HRSA); SENATE; HOUSE OF REPRESENTATIVES

Education EDU

Teaching Health Center Graduate Medical Education, Expanding Medical Education, Rural America Health Corps Act, Doctors of Community Act, REDI Act, Resident Physician Shortage Reduction Act, Rural Physician Workforce Production Act

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. VP Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.